Navigation Links
Agilent Technologies Expands Agreement to Offer AMDeC Members Preferential Pricing on Products Through AMDeC F.I.R.S.T.™ Vendor Partnership Program
Date:11/18/2010

NEW YORK, Nov. 18, 2010 /PRNewswire-USNewswire/ -- AMDeC, the Academy for Medical Development and Collaboration, announced today that Agilent Technologies has renewed and expanded its agreement to offer AMDeC member institutions advanced technology access and discounted pricing on a number of products important for genomics and proteomics research.  AMDeC is a consortium of 22 pre-eminent academic medical research institutions in the New York region.  Agilent is a leading global provider of instrumentation, supplies, software and services to the life science and chemical analysis markets.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100907/DC60414LOGO)

(Logo: http://photos.prnewswire.com/prnh/20100907/DC60414LOGO)

The long-standing relationship between the two organizations is now enhanced with Agilent's listing on AMDeC F.I.R.S.T.™ (Facilities Instrumentation Resources Services & Technologies), the first-ever comprehensive, real-time online registry and database of biomedical research technology and resources.  This will facilitate AMDeC member access to substantial savings through product discounts across the spectrum of Agilent's genomics product lines, including microarray slides, bioreagents, hybridization consumables, and bioanalyzers.  

"Creating ties like this between industry and academia benefits all parties. For our member institutions, this agreement will realize substantial savings, which is especially crucial in this time of constrained budgets," said Maria Mitchell, Ph.D., President of AMDeC.  "For Agilent, this agreement provides greater access to and collaboration with the academic biomedical research community."

"Recognizing the critical role of genomics in advancing scientific research, we are especially pleased to be taking a lead role in encouraging scientific exchange among researchers in this field, in addition to offering value-based solutions to AMDeC member institutions on products in this domain," said Robert Schueren, Agilent vice president and general manager, Genomics and Life Science Reagents.  

In addition to genomics, Agilent is a leading provider of chromatography, mass spectrometry, microscopy, tailored support solutions, and automation solutions. Earlier this year, Agilent placed a mass spectrometer at Mount Sinai School of Medicine for use and access by all of AMDeC's member institutions through AMDeC's Technology Access Program (TAP).  Through a facilitated RFP process, TAP leads to the placement of high technology resources or reagents for use in scientific studies, providing product exposure, real-time validation, and assessment for technology acquisition.

About AMDeC's Vendor Partnership Program and AMDeC F.I.R.S.T.™

AMDeC's Vendor Partnership Program enables AMDeC member institutions to access advanced technologies and discounted pricing.  These valuable partnerships, negotiated by AMDeC on behalf of the entire consortium, leverage AMDeC's collective purchasing power and lead to greater cost efficiencies and economies of scale for all members.  The program also provides early access to the newest biomedical technologies, as well as increased grant competitiveness for AMDeC member institutions.  

Information related to AMDeC's Vendor Partnerships can be found on AMDeC F.I.R.S.T.™, a user-friendly, secure online platform offering a single point of entry to real-time information on core facility services and instruments that are available for use across the entire AMDeC consortium.  This includes information on available laboratories, instruments, resources, services and technologies, which can be accessed on a fee-for-service basis.  Access to AMDeC F.I.R.S.T. and information about AMDeC's Vendor Partnerships are available to AMDeC members.

Log on to www.amdec.org for more information.

About AMDeC

Established in 1997, the Academy for Medical Development & Collaboration, AMDeC, is a consortium of 22 pre-eminent academic biomedical research institutions.  In its 13-year history, AMDeC has led the way towards team science, resource-sharing efforts, member services focused on cost savings and technology access, and private sector participation with academia.  AMDeC has recently debuted AMDeC F.I.R.S.T., the first real-time online registry of biomedical research services and resources in the consortium.

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.


'/>"/>
SOURCE AMDeC
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
2. The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner
3. HCL Technologies Launches AeroPASS Airport Security Solution
4. HCL Technologies Launches AeroPASS Airport Security Solution
5. Biometric ID technologies inherently fallible -- new report
6. AOptix Technologies to Show Combined Biometric Face and Iris Capture System at Biometrics Consortium Conference
7. NHGRI funds development of third generation DNA sequencing technologies
8. Reportlinker Adds Biomarkers - technologies, markets and companies
9. Iowa State awards grants to develop health, energy and research technologies
10. Montana State University offers 6 new biomedical technologies for licensing
11. New Report - Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014) By MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... effects and diminished effectiveness over time. A recent study published in STEM CELLS ... by stimulating subventricular zone (SVZ) stem cells to produce more neural cells. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Executive search firm, ... Avomeen Analytical Services. Harvill is a distinguished life sciences expert with a proven ... a leader in a wide range of services related to laboratory testing and ...
(Date:3/27/2017)... , March 27, 2017 Infectex Ltd., a Russian portfolio company ... clinical study of SQ109 added to the standard drug therapy regimen in patients with ... at Sequella, Inc. ( USA ) and the US National Institutes of ... ... Maxwell Biotech Venture Fund Logo ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... method to engineer scalable and customizable vascular grafts in JoVE’s Video Journal, the ... lead to new and improved ways of treating coronary artery disease (CAD). Lam ...
Breaking Biology Technology: